Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin

Correction to: Ponatinib efficiently kills imatinib-resistant chronic eosinophilic leukemia cells harboring gatekeeper mutant T674I FIP1L1-PDGFRα: roles of Mcl-1 and β-catenin

Bibliographic Details
Main Authors:	Yanli Jin, Ke Ding, Honglin Li, Mengzhu Xue, Xiaoke Shi, Chengyan Wang, Jingxuan Pan
Format:	Article
Language:	English
Published:	BMC 2021-10-01
Series:	Molecular Cancer
Online Access:	https://doi.org/10.1186/s12943-021-01407-6

Similar Items

The conformational control inhibitor of tyrosine kinases DCC-2036 is effective for imatinib-resistant cells expressing T674I FIP1L1-PDGFRα.
by: Yingying Shen, et al.
Published: (2013-01-01)

FIP1L1-PDGFRα p.T674I-D842L: A Novel and Ponatinib Resistant Compound Mutation in FIP1L1-PDGFRα Positive Leukemia
by: Els Lierman, et al.
Published: (2019-04-01)

PB2172: PREVALENCE OF FIP1L1-PDGFRΑ FUSION IN TUNISIAN PATIENTS WITH HYPEREOSINOPHILIA
by: Nermine Torkhani, et al.
Published: (2023-08-01)

BIRC6 mediates imatinib resistance independently of Mcl-1.
by: Denis O Okumu, et al.
Published: (2017-01-01)

The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model
by: Marianne G. Pouwer, et al.
Published: (2018-06-01)

Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β
by: Lingli Zhou, et al.
Published: (2018-07-01)

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
by: Kathryn C. Arbour, MD, et al.
Published: (2022-01-01)

FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India
by: Anıl Kumar N., et al.
Published: (2014-02-01)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
by: Abu-Tineh M, et al.
Published: (2021-12-01)

Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene
by: Pablo García-Martínez, et al.
Published: (2017-04-01)

Rotating between ponatinib and imatinib temporarily increases the efficacy of imatinib as shown in a chronic myeloid leukaemia model
by: H. Jonathan G. Lindström, et al.
Published: (2022-03-01)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation
by: Gueorgui Balatzenko, et al.
Published: (2011-10-01)

Leucemia eosinofílica crônica com expressão do rearranjo FIP1L1-PDGFRα: relato de caso e revisão da literatura
by: Martha M. A. S. Arruda, et al.
Published: (2010-01-01)

Identification of JAK2 as a mediator of FIP1L1-PDGFRA-induced eosinophil growth and function in CEL.
by: Bin Li, et al.
Published: (2012-01-01)

FIP1L1–PDGFRα-Positive Loeffler Endocarditis—A Distinct Cause of Heart Failure in a Young Male: The Role of Multimodal Diagnostic Tools
by: Andreea Varga, et al.
Published: (2023-05-01)

PDGFR-β mediated growth failure in pediatric CML cases on Imatinib
by: Prakamya Gupta, et al.
Published: (2020-09-01)

FIP1L1-PDGFRА-positive myeloproliferative disease with eosinophilia: A rare case with multiple organ dysfunction and a response to tyrosine kinase inhibitor therapy
by: I S Nemchenko, et al.
Published: (2015-12-01)

Imatinib atenua a fibrose miocárdica em associação com a inibição da atividade do PDGFRα Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity
by: Li-kun Ma, et al.
Published: (2012-12-01)

Imatinib atenua a fibrose miocárdica em associação com a inibição da atividade do PDGFRα Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity
by: Li-kun Ma, et al.
Published: (2012-01-01)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
by: Juhi Jain, et al.
Published: (2020-12-01)

Chronic eosinophilic leukemia with Fip 1-like 1-platelet-derived growth factor receptor alpha mutation: A rare case report
by: Khushboo Dewan, et al.
Published: (2015-01-01)

Chitinase-1 Activity in Serum of Cats with FIP
by: Angelica Stranieri, et al.
Published: (2023-08-01)

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL
by: Elias Jabbour, et al.
Published: (2023-08-01)

The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
by: Stewart, Michelle L., et al.
Published: (2012)

Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer
by: Elizabeth Mack, et al.
Published: (2011-05-01)

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
by: Valentina Giudice, et al.
Published: (2020-12-01)

P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
by: Philipp Le Coutre, et al.
Published: (2023-08-01)

Pref-1, a Gatekeeper of Adipogenesis
by: Carolyn S Hudak, et al.
Published: (2013-07-01)

Inhibition and Mechanism of Imatinib on A549 Xenograft Tumor in Nude Mice via PDGF/PDGFR Pathway
by: XIA Bingtian, et al.
Published: (2023-09-01)

MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis.
by: Jae-Hong Kim, et al.
Published: (2013-01-01)

miR-107 activates ATR/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.
by: Chengyan Zhou, et al.
Published: (2014-01-01)

Nicolas Patin, La Catastrophe allemande (1914-1945), 1 674 destins parlementaires
by: Agathe Bernier-Monod
Published: (2016-04-01)

The FIP and Inverse FIP Effects in Solar and Stellar Coronae
by: J. Martin Laming
Published: (2015-09-01)

Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
by: Simone Romagnoli, et al.
Published: (2021-11-01)

Corrigenda: Revision of the Neotropical green lacewing genus Ungla (Neuroptera, Chrysopidae). ZooKeys 674: 1–188. https://doi.org/10.3897/zookeys.674.11435
by: Catherine A. Tauber, et al.
Published: (2017-08-01)

FIPs and Practice
by: Barbara Magagna, et al.
Published: (2022-10-01)

WorldFIP
by: Marc Desjardins
Published: (1994-03-01)

Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression
by: Kadivar, Ali, et al.
Published: (2018)

LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA
by: Duan Li, et al.
Published: (2021-05-01)

Iterative optimization yields Mcl-1–targeting stapled peptides with selective cytotoxicity to Mcl-1–dependent cancer cells
by: Bird, Gregory H., et al.
Published: (2018)